Riverside Partners, a private equity firm focused on investing in middle market healthcare and technology companies, today announced the closing of Riverside Fund V with USD561 million of committed capital.
Riverside Fund V follows the firm’s USD406 million Riverside Fund IV, which was raised in 2009. Riverside Partners was able to secure very significant support from its existing investors. Fund V builds on the firm’s 23-year track record of partnering with founder- and management-owned healthcare and technology companies.
"We are very pleased to have completed our fundraising, achieving our hard cap in six months. We are particularly appreciative of the substantial support from our existing investors, as well as several new investors, during a crowded fundraising environment," says David Belluck (pictured), General Partner at Riverside Partners, LLC. "We are excited about the new fund’s prospects. Our team continues to actively invest in healthcare and technology businesses that are consistent with the businesses we have worked with over our 23-year history."
Atlantic-Pacific Capital Inc. served as Riverside’s placement agent for Riverside Fund V. Choate, Hall & Stewart, LLP served as counsel to the fund.
